NasdaqGS - Delayed Quote USD
Anika Therapeutics, Inc. (ANIK)
10.93
-0.34
(-3.02%)
At close: June 13 at 4:00:01 PM EDT
10.93
0.00
(0.00%)
After hours: June 13 at 4:04:15 PM EDT
Insider Purchases Last 6 Months
| Aktien | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 591.01k | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Aktien | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| GRIFFIN STEPHEN D Chief Operating Officer | -- | Direct | -- | Jun 3, 2025 |
| NUNES ANNE Chief Operating Officer | -- | Direct | -- | Mar 17, 2025 |
| BLANCHARD CHERYL R Chief Executive Officer | -- | Direct | -- | Mar 17, 2025 |
| COLLERAN DAVID B J.D. General Counsel | -- | Direct | -- | Mar 17, 2025 |
| NUNES ANNE Chief Operating Officer | -- | Direct | -- | Mar 11, 2025 |
| BLANCHARD CHERYL R Chief Executive Officer | -- | Direct | -- | Mar 11, 2025 |
| COLLERAN DAVID B J.D. General Counsel | -- | Direct | -- | Mar 11, 2025 |
| NUNES ANNE Chief Operating Officer | -- | Direct | -- | Mar 10, 2025 |
| BLANCHARD CHERYL R Chief Executive Officer | -- | Direct | -- | Mar 10, 2025 |
| COLLERAN DAVID B J.D. General Counsel | -- | Direct | -- | Mar 10, 2025 |
| NUNES ANNE Chief Operating Officer | -- | Direct | -- | Oct 1, 2024 |
| JELLISON WILLIAM R Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 9, 2024 |
| HENNEMAN JOHN BELL III Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 9, 2024 |
| VOGT SUSAN L N Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 9, 2024 |
| CONLEY SHERYL L Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 9, 2024 |
| CAPPER JOSEPH H Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 9, 2024 |
| LARSEN GLENN R Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 9, 2024 |
| RICHARD STEPHEN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 9, 2024 |
| FISCHETTI GARY P. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 9, 2024 |
| JELLISON WILLIAM R Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 3, 2024 |
| CAPPER JOSEPH H Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 3, 2024 |
| NUNES ANNE Chief Operating Officer | -- | Direct | -- | Mar 11, 2024 |
| BLANCHARD CHERYL R Chief Executive Officer | -- | Direct | -- | Mar 11, 2024 |
| LEVITZ MICHAEL L. Chief Financial Officer | -- | Direct | -- | Mar 11, 2024 |
| COLLERAN DAVID B J.D. General Counsel | -- | Direct | -- | Mar 11, 2024 |
| NUNES ANNE Chief Operating Officer | -- | Direct | -- | Sep 29, 2023 |
| LEVITZ MICHAEL L. Chief Financial Officer | -- | Direct | -- | Aug 10, 2023 |
Related Tickers
CPIX Cumberland Pharmaceuticals Inc.
5.24
-10.58%
COLL Collegium Pharmaceutical, Inc.
29.18
-1.42%
LFCR Lifecore Biomedical, Inc.
6.73
-1.46%
PBH Prestige Consumer Healthcare Inc.
83.97
-1.37%
AMPH Amphastar Pharmaceuticals, Inc.
25.82
-2.34%
KMDA Kamada Ltd.
6.88
-0.86%
INDV Indivior PLC
13.89
-0.29%
LJUIF SSY Group Limited
0.6987
0.00%
BJTRF Beijing Tong Ren Tang Chinese Medicine Company Limited
0.6484
0.00%
CSWYF China Shineway Pharmaceutical Group Limited
1.0040
0.00%